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Abstract
Introduction: The detection and prevention of errors in the postanalytical phase can be done through the harmonization and standardization 
of constituent parts of this phase of laboratory work. The aim was to investigate how well the ongoing management of the postanalytical phase 
corresponds to the document “Post-analytical laboratory work: national recommendations” in Croatian medical biochemistry laboratories (MBLs).
Materials and methods: All 195 MBLs participating in the national external quality assessment scheme, were invited to undertake a part in a 
survey. Through 23 questions the participants were asked about management of the reference intervals (RI), delta check, reflex/reflective testing, 
postanalytical quality indicators and other parts of the postanalytical phase recommended in the national recommendations. The results are pre-
sented in numbers and percentages. 
Results: Out of 195 MBLs, 119 participated in the survey, giving a response rate of 61%. Not all of the respondents provided answers to all the que-
stions. Delta check has not been used in 59% (70/118) of the laboratories. Only 22/113 (20%) laboratories use reflex and/or reflective testing. In 53% 
of the laboratories, critical results were reported within 30 minutes of the confirmation of the results. In 34% (40/118) of the laboratories, turnaro-
und time and reporting of critical results are two most often monitored postanalytical quality indicators.
Conclusion: The results showed the critical results reporting and monitoring of postanalytical quality indicators are in the line with the recommen-
dations. However, the management of RI verification, the use of delta check and reflex/reflective testing still must be harmonized among Croatian 
MBLs.
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Introduction
In the past few decades, informatization has con-
tributed to the improvement of the total testing 
process, and it has carried out a significant role in 
minimizing errors in the postanalytical phase. In-
formatization enables the effective release of lab-
oratory test results, turnaround time (TAT) moni-
toring, and improves the timeliness of notification 
of critical results. Despite that, 13-20% of errors in 
the total testing process are still postanalytical er-
rors (1,2).
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Defining protocols to be followed in the postana-
lytical phase of laboratory work is necessary to re-
duce errors, but also to facilitate the harmoniza-
tion of this ultimate step in laboratory testing. To 
improve the postanalytical phase of laboratory 
work, each laboratory must define quality indica-
tors to be monitored, one of the fundamental re-
quirements for the accreditation of a clinical labo-
ratory (3,4). The process of monitoring and im-
proving the key components of the postanalytical 
phase goes beyond the TAT and critical result 
monitoring, the usual quality indicators followed 
by the laboratories. It should also address the use 
of delta check, repeat testing, reference intervals 
(RIs), and interpretative comment (5,6). 
Delta check has been proven to be a good tool for 
improving the postanalytical as well as preanalyti-
cal phase. It is especially significant for the results 
falling within the critical limits defined by the labo-
ratory. Repeating measurements for results within 
the critical limits remain the standard practice in 
many laboratories, despite the recommendations 
that the results without the flag coming from the 
analyser with accepted quality control are unnec-
essary. Recognition, documentation, and notifica-
tion of critical results, as well as prompt communi-
cation to a physician, are crucial for patient safety 
(3,5,7). 
Each laboratory test report must contain units of 
measurement, followed by appropriate RI for the 
specific age-group. In addition to the RIs on the 
laboratory test report, an interpretative comment 
may also be important for physicians because it fa-
cilitate the interpretation of test results (7). Turna-
round time is the most common quality indicator 
of the postanalytical phase. It is significant to em-
phasize that delays in any phase of laboratory 
work may lead to an increased TAT (e.g., repeat 
testing or preanalytical errors like sample clot or 
haemolysed sample) (5,8).
In 2019 the Working Group for Postanalytics of the 
Croatian Society of Medical Biochemistry and Lab-
oratory Medicine (CSMBLM) published the docu-
ment “Post-analytical laboratory work: national 
recommendations” for the postanalytical phase of 
laboratory work covering the main topics such as 
the evaluation of test results, the release of the 
laboratory test report, sample storage and dispos-
al, the archiving of laboratory documentation, and 
managing postanalytical quality indicators. The 
recommendations were issued in an attempt to 
contribute to the harmonization of the postanalyt-
ical phase of laboratory work in Croatia (7).
This study represents the first comprehensive 
evaluation of the management of some key ele-
ments of the postanalytical phase of laboratory 
work in Croatian medical biochemistry laborato-
ries (MBLs) after the national recommendations 
has been published. Recognising that the imple-
mentation of national recommendations is not ob-
ligatory, their utilization and implementation can 
be considered good laboratory practice and the 
improvement of laboratory work.
The study aimed to investigate how well the on-
going management of the postanalytical phase in 
Croatian MBLs corresponds to the document 




A study in the form of a survey was conducted by 
the Working Group for Postanalytics in collabora-
tion with the Croatian Centre for Quality Assess-
ment in Laboratory Medicine, both within the 
CSMBLM. An online invitation was extended in 
September 2019 to all 195 MBLs in Croatia. Labora-
tories’ participation in the survey was optional and 
voluntary. All the respondents to the survey were 
taken into consideration and the laboratories that 
did not answer the particular question were not 
excluded.
The survey was part of Module 10 entitled “Posta-
nalytical phase of laboratory testing” and con-
ducted as a part of the national external quality as-
sessment scheme. It contained 23 questions and 
laboratories’ anonymity was assured through code 
numbers which were selected by the participants. 
The questionnaire had been designed according 
to the document “Post-analytical laboratory work: 
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national recommendations”. The questions (yes/
no and multiple-choice questions) in the survey 
assessed the laboratory management of the key 
elements of the postanalytical phase; RI, delta 
check, reflex and/or reflective testing, reporting of 
critical results, sample storage, and postanalytical 
quality indicators. 
Data analysis 
The results were obtained by counting and are 
presented in numbers and percentages. The per-
centage was calculated according to the total 
number of answers to the particular question. The 
concordance was characterized as satisfactory 
when more than half of the answers to a particular 
question were in the line with the national recom-
mendations. The data analysis was carried out us-
ing Microsoft Excel version 2016 (Microsoft, Red-
mond, USA). 
Results
Out of 195 MBLs in Croatia, 119 participated in the 
survey, giving a response rate of 61%. However, 
not all of the respondents provided answers to all 
the questions. Overall survey results are presented 
in Table 1.
In the absence of RI recommended by the Croa-
tian Chamber of Medical Biochemists (CCMB), 79% 
of the participating laboratories will use a RI de-
clared by the in vitro diagnostics (IVD) manufactur-
er. Results showed that 63% (71/113) of the re-
spondents had not conducted a verification of the 
acceptability of the applied RI in their laboratory 
(Table 1). The reasons for such practice were pro-
vided by 46 out of 71 of the participating laborato-
ries: 15/46 of them mentioned economic reasons 
and/or lack of personnel for such practice, while 
the inability to gather enough representative sam-
ples was the reason pointed out by 11/46 of par-
ticipating laboratories. The majority of laborato-
ries, 20/46, considers the RIs issued by the CCMB 
reliable enough. 
When asked about the management of laboratory 
reports in the absence of RI for a particular age 
group, only 17% (19/114) of the laboratories an-
swered, stating the following reasons: some had 
not encountered such a situation (11/19), and some 
use the RI from the literature (8/19). In such cases, 
the result is accompanied by the explanation in 
the “Comments” area on the laboratory report. 
Delta check has not been used in the majority of 
the participating laboratories (59%) and among 
those that use it, only 21 laboratories implement-
ed delta check in the LIS. Furthermore, those labo-
ratories that use delta check, reported delta per-
cent check and reference change value as the two 
most used methods of delta check in the LIS. More 
than two-thirds of the laboratories (72%) have set 
their timeframe of delta check longer than five 
days. 
Only 22 out of 113 (20%) laboratories use reflex 
and/or reflective testing in their work. It is most of-
ten used in the field of biochemistry (15/22) and 
least often in coagulation (1/22). 74% of the labora-
tories will report critical result after repeating the 
analysis; 53% of the laboratories would do it within 
30 minutes of the confirmation of critical result 
and 84% keeps a record of the critical result re-
porting (Table 1).
A total of 86 out of 118 laboratories (73%) monitor 
some type of quality indicators of the postanalyti-
cal phase, mostly TAT (34%) and the notification of 
critical results (34%) (Table 1). 
Discussion
The results reveal variations among Croatian labo-
ratories in the receptivity towards the procedures 
to be followed in the postanalytical phase. 
As defined by the national recommendations, lab-
oratory test results should not be issued without 
corresponding RI for each analyte and the practice 
to be followed in the absence of RI has also been 
defined (7,9). Survey results revealed that the prac-
tice of all MBLs is concordant with the national rec-
ommendations in the nonexistence of RI recom-
mended by the CCMB; other sources of RI have 
been chosen.  In such cases, most Croatian labora-
tories would choose an RI declared by the IVD 
manufacturer, demonstrating an understanding of 
the importance of the RI that accompanies the re-
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Question and answer n/N, (%)
1. What type of health care setting does your laboratory belong to?
A. Primary health care 78/119 (66)
B. Secondary health care 30/119 (25)
C. Tertiary health care 11/119 (9)
2. When there is no reference interval recommended by the Croatian Chamber of Medical Biochemists (CCMB), which 
other source do you use for the reference interval?
A. Reference interval declared by the reagent manufacturer 91/115 (79)
B. Reference interval as a result of multi-centric studies 1/115 (1)
C. Reference interval from literature and the current state-of-the-art 23/115 (20)
3. Have you verified the acceptability of the applied reference interval in your laboratory? 
A. Yes 42/113 (37)
B. No (Please give a reason) 71/113 (63)
4. What do you do when there is no reference interval for a particular age group of patients?
A. We combine with the next age group and issue a result with a reference interval of that age group 53/114 (46)
B. We issue the result without the corresponding reference interval with an explanation in the “Comments” 
    area on the laboratory test report 42/114 (37)
C. Other, please specify 19/114 (17)
5. Do you have a delta check (testing the difference between two consecutive results for the same patient) implemented 
in the laboratory information system (LIS)?
A. Yes 21/118 (18)
B. No, we use the manual calculation method 27/118 (23)
C. We do not use delta check at all 70/118 (59)
6. If the answer to the previous question is Yes, how did you define “delta check” in LIS? *
A. Reference change value 6/21
B. Delta difference 3/21
C. Delta percent change 10/21
D. Rate difference 0/21
E. Rate percent change 2/21
7. For which areas of Clinical Chemistry do you use delta check (more answers possible)?
A. General biochemistry 27/86 (31)
B. Haematology 26/86 (30)
C. Coagulation 21/86 (24)
D. Special biochemistry 15/86 (17)
E. Emergency laboratory test 13/86 (15)
F. Other, please specify 2/86 (2)
G. We do not use it 52/86 (61)
8. Which is the timeframe of delta check in your laboratory? *
A. 1-3 days 4/32
B. 2-5 days 5/32
C. > 5 days 23/32
Table 1. Distribution of participants’ answers regarding the management of the postanalytical phase among Croatian laboratories 
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9. How do you handle a sample when diluting it manually?
A. According to the manufacturer’s instructions 76/118 (65)
B. According to our protocol 12/118 (10)
C. We do not dilute manually; we only use automatic dilution from the analyser 30/118 (25)
10. What do you consider the most justifiable reason to repeat the measurement (more answers possible)?
A. A result accompanied by a remark from the analyser, whether inside or outside the measuring range 95/119 (80)
B. A result that has no remark from the analyser but is outside the measuring range 77/119 (65)
C. A result that is discrepant with other results 91/119 (77)
D. A result that is inconsistent with the patient’s diagnosis 73/119 (61)
11. Do you use reflex and/or reflective testing in your laboratory? 
A. Yes (Please specify) 22/113 (20)
B. No 91/113 (80)
12. A physician requested total and direct bilirubin. The value of total bilirubin is within the reference interval. What 
would you do?
A. Regardless of the value of total bilirubin, direct bilirubin was determined because the physician asked for it 75/95 (79)
B. First, determine total bilirubin and based on the obtained value proceed according to the laboratory 
    protocol on reflex testing 20/95 (21)
13. What is your primary source of the critical results?
A. The CCMB document “Critical Laboratory Findings and Critical Result Reporting” 119/119 (100)
B. International professional organizations (the EFLM, the IFCC) 0/119 (0)
C. Other literary sources 0/119 (0)
14. Do you report a critical result as soon as you get it or after a repeated testing?
A. Yes, immediately 21/119 (18)
B. Sometimes 10/119 (8)
C. After repeated measurement 88/119 (74)
15. In what period do you report a critical result?
A. Within 30 minutes of the confirmation of results 62/118 (53)
B. Within one hour of the confirmation of results 9/118 (7)
C. When we manage to get a physician/department 47/118(40)
16. Do you keep a record of the reported critical results? 
A. Yes 99/118 (84)
B. Sometimes 7/118 (6)
C. No 12/118 (10)
17. Do you use the recommended standardized remarks in the “Comments” area of the laboratory test report?
A. Yes, whenever possible 79/119 (66)
B. Sometimes 13/119 (11)
C. No, we have our own notes 27/119 (23)
18. If the obtained test result requires additional interpretation, what do you do?
A. We notify the requesting physician/department 37/119 (31)
B. We explain in the “Comments” area on the laboratory test report 15/119 (13)
C. We explain in the “Comments” area on the laboratory test report and personally notify the requesting 
     physician/department 64/119 (54)
D. We do not have such cases 3/119 (2)
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19. How long do you keep the samples after analysis?
A. 24 hours 41/119 (35)
B. 48 hours 36/119 (30)
C. > 48 hours 8/119 (7)
D. We throw them away at the end of the workday due to lack of adequate storage space 3/119 (2)
E. As long as it is recommended for each type of sample/analysis 31/119 (26)
20. Which postanalytical phase quality indicators do you monitor in your laboratory?
A. Turnaround time (TAT) 40/118 (34)
B. Percentage of incorrect (revoked) laboratory test reports 6/118 (5)
C. Reporting critical results 40/118 (34)
D. We do not monitor them 32/118 (27)
21. How do you monitor TAT in your laboratory?
A. From the time of registration of the request in the LIS to the time of confirmation/validation of the test result 52/118 (44)
B. From the time of sampling to the time of confirmation/validation of the test result 16/118 (14)
C. We do not monitor TAT 50/118 (42)
22. In what form do you most often issue a laboratory test report?
A. On paper, to patients who come to the laboratory 9/118 (8)
B. On paper, to physician/wards 11/118 (9)
C. Electronically, via Hospital information system 98/118 (83)
23. Do you send patients their laboratory test reports by e-mail?
A. Yes 21/119 (18)
B. Yes, but they must first file a request to send the laboratory test report by e-mail 48/119 (40)
C. No 50/119 (42)
Results are presented as the number of answers to each offered question option (n) and the percentage (%) of the total number 
of answers (N) to a particular question. *Due to the small sample size results are not presented with the percentage. IVD – in vitro 
diagnostic. CCMB – Croatian Chamber of Medical Biochemists. EFLM – European Federation of Clinical Chemistry and Laboratory 
Medicine. IFCC – International Federation of Clinical Chemistry and Laboratory Medicine.
sult issued by the laboratory (10). Presumably, the 
accessibility of RI coming from the IVD manufac-
turer and their supposed reliability (because of le-
gal requirements for the manufacturers in provid-
ing suitable RI) are the reasons for laboratories not 
to proceed with the extensive work in providing 
their own RI for a stated analyte (11). 
One of the requirements of the International Or-
ganization for Standardization ISO 15189:2012 and 
national recommendations is that the laboratory 
periodically evaluates RIs (4,7). Most of the sur-
veyed Croatian laboratories have not performed 
such evaluation. The obstacles for the verification 
of the RI mentioned by the laboratories in this sur-
vey (e.g., availability of referent population and 
time-consuming process) are the same ones dis-
cussed by several prominent laboratory experts 
(12). Establishing own RI is even more challenging 
work for many reasons, such as selecting the rep-
resentative population (e.g., “healthy” geriatric 
population), harmonizing the preanalytical phase 
(e.g., fasting vs non-fasting), and standardizing the 
analytical phase (e.g., methods, calibrators) (13). 
The determination of RIs for the paediatric popula-
tion places several other obstacles in front of the 
laboratory in terms of recruiting an adequate 
number of healthy children in each age-group, 
collecting sufficient blood volume, and defining 
RIs for the biomarkers showing alternations associ-
ated with the child’s growth (e.g., alkaline phos-
https://doi.org/10.11613/BM.2021.030704 Biochem Med (Zagreb) 2021;31(3):030704 
  7
Jokic A. et al. The postanalytical phase in Croatian laboratories 
mented in the Croatian study; 63% of the laborato-
ries report the critical result within 15 minutes and 
28% within 30 minutes after the measurement 
(22,23).
Incorrect laboratory reports, TAT, and the notifica-
tion of critical results are three recommended 
quality indicators for the postanalytical phase (5,7). 
Our results show one-third of the laboratories do 
not meet these minimum standards. One of the 
reasons might be that most of our responders 
come from the primary health care settings, where 
the laboratory work is organized in a way that the 
results are issued after the routine work is done, or 
even the next working day. Such organization di-
minishes the need for the prompt laboratory re-
sults release. In the survey conducted by Preston, 
33% of the laboratories monitor TAT, which is re-
markably similar to our results (34%). However, the 
before mentioned study reported 62% of the lab-
oratories monitoring notification of critical results, 
which is almost double what was reported in our 
study (24).
Our survey contains some limitations. We had not 
conducted questionnaire validation, which was 
potentially reflected on the quality of the survey. 
The time between the publication of the national 
recommendations and the conducted survey was 
three months and arguably this time was not long 
enough for the laboratories to implement recom-
mendations thoroughly. That may be one of the 
reasons for the weaker implementation of the rec-
ommendations in some parts of the postanalytical 
phase. Furthermore, the number of participating 
laboratories from the secondary and tertiary 
health care settings was relatively limited, which 
contributes to not possessing much more insight 
into their management of the postanalytical 
phase. In the previous study conducted shortly af-
ter the publication of the national recommenda-
tions, autovalidation was surveyed (25). For that 
reason, autovalidation was not included in this 
survey.
In conclusion, this study was the attempt to inves-
tigate the agreement of laboratories’ manage-
ment of postanalytical phase to the national rec-
ommendations. The issues with low concordance 
phatase) (14). In such cases, one of the solutions 
could be a verification of RIs from the pre-existing 
paediatric database as it was shown in the study 
by Zrinski Topic et al. or conducting a posteriori 
study (15,16).
A relatively low concordance to the national rec-
ommendations regarding the use of delta check 
can be attributed to the fact that most laborato-
ries were from primary health care settings. In 
those laboratories, the period between consecu-
tive test results for the same patient is ordinarily 
more than the recommended 2-5 days, which 
makes the use of a delta check in primary health 
care laboratories questionable (7). Studies con-
ducted in different health care systems and set-
tings show the benefits of implementing delta 
check in daily work regarding, e.g., detection of 
specimen mix-up errors, contaminated specimen 
(e.g., IV fluid), and analytical error (17,18).
In a contemporary laboratory, reflex and/or reflec-
tive testing can add a new dimension to the purely 
analytical service of obtaining and issuing test re-
sults. Studies have shown that both physicians and 
patients view reflective testing favourably because 
it can assist in the process of establishing the pa-
tient diagnosis (19). Nonetheless, according to our 
results, most Croatian laboratories do not use re-
flex and/or reflective testing. The plausible reason 
is that most of the surveyed laboratories were 
from the primary health care settings, where or-
ganisation of primary health care settings on the 
national level disables a laboratory from conduct-
ing additional testing before consulting with a re-
questing physician. The International Federation 
of Clinical Chemistry and Laboratory Medicine 
considers reporting of critical results as one of the 
important indicators of the postanalytical phase 
quality control (20). Most of the surveyed Croatian 
laboratories report critical results after repeat test-
ing and half of them to report it within 30 minutes 
of the confirmation of the results, as recommend-
ed (7). The College of American Pathologists in its 
Q-Probes survey reported 61% of the laboratories 
retest critical chemistry results (21). In the Portu-
guese study, 60% of the laboratories notify critical 
results within 15 minutes and 33% within 30 min-
utes of the timeframe. Similar results are docu-
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are RI verification, the use of delta check, and the 
reflex/reflective testing since more than half of re-
ported results differ from the national recommen-
dations. At the same time, critical results reporting 
and monitoring of the postanalytical quality indi-
cators indicate satisfactory concordance with the 
national recommendations. Although the results 
revealed that the overall postanalytical phase 
management has room for improvement, there is 
a promising basis for the future harmonization 
and standardization of the postanalytical phase in 
Croatian MBLs.
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